Gold Standard Diagnostics Receives FDA 510K for Lyme IgG and IgM EIA Kits

DAVIS, Calif.--(BUSINESS WIRE)--The Gold Standard Diagnostics Group (GSD) today announced the immediate availability of their two new Lyme IgG and Lyme IgM EIA kits for detection of antibodies against Lyme disease causing bacteria. The two assays give laboratories a more diverse arsenal of testing methodologies that allows them to achieve more reliable results. The assays are available immediately in the US. The separate IgG and IgM assays provide laboratories the ability to offer more specific

Click to view original post